Granatum Bioworks is an affordable lab-to-market platform for biosynthetics, focused on LATAM customer needs.
Granatum Bioworks has raised $833K in total funding. The most recent round was Convertible Note. The last funding was announced in January 2023.
Granatum Bioworks's investors include Life Is Too Short Capital, Labcap, Cibeles Corporacion, Grupo Auran.
Granatum Bioworks is headquartered in Monterrey, Mexico.
Granatum Bioworks is an affordable lab-to-market platform for biosynthetics, focused on LATAM customer needs.
Granatum Bioworks is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Granatum Bioworks — Funding & Investors." VCBacked, January 6, 2023, https://www.vcbacked.co/company/granatum-bioworks. Accessed September 30, 2026.
VCBacked. (2023). Granatum Bioworks — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/granatum-bioworks
{{cite web |title=Granatum Bioworks — Funding & Investors |url=https://www.vcbacked.co/company/granatum-bioworks |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated